SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-008296
Filing Date
2020-07-22
Accepted
2020-07-22 16:10:47
Documents
14
Period of Report
2020-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20200720x8k.htm   iXBRL 8-K 46070
2 EX-99.1 imgn-20200720xex99d1.htm EX-99.1 12000
3 GRAPHIC imgn-20200720xex99d1001.jpg GRAPHIC 5021
  Complete submission text file 0001558370-20-008296.txt   189746

Data Files

Seq Description Document Type Size
4 EX-101.SCH imgn-20200720.xsd EX-101.SCH 3037
5 EX-101.LAB imgn-20200720_lab.xml EX-101.LAB 16753
6 EX-101.PRE imgn-20200720_pre.xml EX-101.PRE 9900
7 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20200720x8k_htm.xml XML 4646
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 201041610
SIC: 2834 Pharmaceutical Preparations